New therapeutic options in congestive heart failure: Part II.
McMurray
John
J
Clinical Research Initiative in Heart Failure, University of Glasgow, Scotland. J.McMurray@bio.gla.ac.uk
Pfeffer
Marc A
MA
D000465:Algorithms; D002304:Cardiac Pacing, Artificial; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy; D016207:Cytokines / Q000037:antagonists & inhibitors; D017147:Defibrillators, Implantable; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015444:Exercise; D006333:Heart Failure / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D018487:Ventricular Dysfunction, Left / Q000628:therapy
D002317:Cardiovascular Agents; D016207:Cytokines; D004791:Enzyme Inhibitors; D061965:Matrix Metalloproteinase Inhibitors